LogoBeta Software
Open Drug Discovery Intelligence
searchSearch Scibite.com

Targets, Diseases & Drug Names All News
SCIBITE NEWS: Welcome to SciBite version 1.9! Read More On This Release which includes enhanced support of Epigenetics, MicroRNAs, Ion Channels and much more!

Methods For Treating Hyperlipidemia With Intermediate Release Nicotinic Acid Compositions Having Unique Biopharmaceutical Characteristics
Tue Apr 3 22:52:25 BST 2012
 Welcome
 Homepage - Explore SciBite
 What is SciBite?
 Getting Started Video
Key Topics

Click on any of the topic names to view its own newsletter. The text we matched to the topic is shown in grey underneath.

 Simcor  

[matched:nicotinic acid]

 Hyperlipidemias  

[matched:hyperlipidemia]

 Flushing  

[matched:flushing]

   
Methods for treating hyperlipidemia with intermediate release nicotinic acid formulations having unique biopharmaceutical characteristics, without causing drug-induced hepatotoxicity to a level which would require discontinuation of the therapy, whereby a majority of the nicotinic acid is release and metabolized in the individual within about 5 to about 9 hours. The present methods of treatment also contemplate administering the intermediate release nicotinic acid formulations composition according to a titrated dosage regimen to reduce flushing;   Read more on this story here

Source: Patent #US2012035225   (view original)

Did You Know?
Our new kinase portal provides daily updates across the entire family? Find new clinical trials, disease connections, patents and competitor intelligence today!